Hôpital Saint Eloi - Bâtiment INM
80, rue Augustin Fliche - BP 74103
34091 Montpellier cedex 5 - France
Tel.: (33) (0)4 99 63 60 00
Fax: (33) (0)4 99 63 60 20

Access to "Saint Eloi" Hospital :

  • By car: Highway A9 - Take the exit «Montpellier Est - Millenaire» Direction «Centre-Ville», then direction «Hôpitaux-Facultés» finally, direction «Hôpital Gui de Chauliac-St Eloi».
  • By train or by shuttle from the airport: Get off the train at «Montpellier Saint Roch» and change to tramway.
  • By Tramway: From train station, take the line in direction «Mosson» and stop at «Saint Eloi ».






Access to INM's building in the hospital :

  • Arrival by tramway:
    At Saint Eloi station, leave the tramway and walk up the «Emile Bertin Sans» street to the gate located on the right, 100 m ahead. Turn directly in the path of right-hand side and walk 100 m to reach the INM on the right.
  • Arrival by car:
    Enter by the main entry of the hospital campus at the «Augustin Fliche» street.
  • For deliveries:
    Turn on right-hand side of the building. An entry with a downward ramp is reserved (do not ring at the main entry of the building).




To live in Montpellier 
Some links to prepare your stay in Montpellier
Montpellier Tourist Website 



The Institute for Neurosciences of Montpellier (INM) is an Inserm/University of Montpellier structure, directed by Professor Jean-Luc Puel, and which thematic are development and pathophysiology of the central and peripheric nervous system, including sensorial organs.

It is composed of 9 teams, including 3 ATIP-Avenir teams:

Team Genetics and therapy of retinal blindness and optic neuropathies, heads by Pr Agnes Muller,

Team Deafness, tinnitus and therapies, heads by Pr Jean-Luc Puel,

Team Somatosensory system development and pathology, heads by Dr Patrick Carroll,

Team Plasticity, stem cells and glial tumors, heads by Pr Hughes Duffau,

Team Motoneuron disease: neuroinflammation and therapy, heads by Dr Cedric Raoul,

Team ATIP-Avenir The Ubiquitin Proteasome System in neurodegeneration and cytoskeleton architecture, heads by Dr Pascale Bomont,

Team Molecular mechanisms of myelination/demyelination and gene therapy approaches in peripheral nerves, heads by Dr Nicolas Tricaud,

Team ATIP-Avenir Neural cell diversity and balance in brain development and pathologies, heads by Dr Karine Loulier,

Team ATIP-Avenir Development and Physiopathology of the anterior segment of the eye, heads by Dr Frédéric Michon.


The work of these teams is carried by technical platforms dedicated to allow functional exploration, histology studies, tissue, cellular and subcellular imaging, genetics, proteomics, in situ hybridization and cell differentiation.

The INM belongs to the labEX “Epigenmed” and to EuroBiomed, the Pole of Excellence dedicated to rare diseases. We strengthen the development of new therapeutic molecules through a partnership with the National graduate school of chemistry of Montpellier and SANOFI. We are actively involved in the set-up of the Medical Health Cluster of Montpellier (Pole Rabelais Biologie-Santé). Partnership with the future “Université Sud de France” provides PhD students with a deep understanding in the field of Biology/Health. The number of masters and PhD degrees from the INM demonstrates the breadth of our students' research, spanning engineering/physical sciences, basic biological sciences and clinical sciences (32 master and 22 PhD students, and 10 post docs in average per year).

During the last four years, U1051 developed scientific cooperations with private companies (Sanofi, Cellectis). In addition, several researchers are consultants in private companies (Soffinova partner, BetaInnov, Sensorion, Biolux or Sanofi). This led to 9 patents (Inserm or CNRS) deposited in partnership with private companies since 2008. We are also involved in the EuroBioMed pole of competitivity (Eurocom for cochlea implant).